Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 81.
381. lappuse
... monohydrate ...... do ...... do 1.25 mg . Cloxacillin sodium monohydrate ...... do ...... do 1.25 mg . Dicloxacillin sodium monohydrate ...... do 1 1.25 mg . Cyclacillin ...... do Distilled water 1.0 mg . Methicillin sodium monohydrate ...
... monohydrate ...... do ...... do 1.25 mg . Cloxacillin sodium monohydrate ...... do ...... do 1.25 mg . Dicloxacillin sodium monohydrate ...... do 1 1.25 mg . Cyclacillin ...... do Distilled water 1.0 mg . Methicillin sodium monohydrate ...
383. lappuse
... monohydrate . Cyclacillin Diluent ( solution number as listed in § 436.101 ( a ) ) Final con- centration in milli ... monohydrate . Methicillin sodium 1 monohydrate . Nafcillin sodium monohydrate 1 Oxacillin sodium monohydrate 1 ...
... monohydrate . Cyclacillin Diluent ( solution number as listed in § 436.101 ( a ) ) Final con- centration in milli ... monohydrate . Methicillin sodium 1 monohydrate . Nafcillin sodium monohydrate 1 Oxacillin sodium monohydrate 1 ...
389. lappuse
... monohydrate tablets .. Cephradine dihydrate capsules . Clarithromycin tablets . Doxycycline hyclate tablets . Doxycycline monohydrate hydrochloric❘ acid capsules .. Erythromycin particles in tablets Loracarbef capsules . § 436.215 ...
... monohydrate tablets .. Cephradine dihydrate capsules . Clarithromycin tablets . Doxycycline hyclate tablets . Doxycycline monohydrate hydrochloric❘ acid capsules .. Erythromycin particles in tablets Loracarbef capsules . § 436.215 ...
392. lappuse
... monohydrate . Assay for cephalexin ac- tivity of the cephalexin hydrochloride monohydrate as directed in §442.28 of this chapter , and use U.S.P. dissolution apparatus 1 ( 10 mesh basket ) . Use the sample as it is removed from the dis ...
... monohydrate . Assay for cephalexin ac- tivity of the cephalexin hydrochloride monohydrate as directed in §442.28 of this chapter , and use U.S.P. dissolution apparatus 1 ( 10 mesh basket ) . Use the sample as it is removed from the dis ...
423. lappuse
... monohydrate with suffi- cient mobile phase to obtain 100 milli- liters , and mix . ( c ) Mobile phase . Methanol : water : 0.2M monobasic sodium phosphate : 10 per- cent tetrabutylammonium hydroxide ( 450 : 447 : 100 : 3 ) adjusted to ...
... monohydrate with suffi- cient mobile phase to obtain 100 milli- liters , and mix . ( c ) Mobile phase . Methanol : water : 0.2M monobasic sodium phosphate : 10 per- cent tetrabutylammonium hydroxide ( 450 : 447 : 100 : 3 ) adjusted to ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning